Doaa Abdelmonsif currently works as an assistant professor at the Department of Medical Biochemistry (Faculty of Medicine), Alexandria University. Doaa does research in the fields of cancer, nanomedicine and molecular biology. Their most recent publication is 'Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients.'